Mr. Henk Brulleman is an Angel Investor. He serves as Board Member at BBB Therapeutics and Biomx. He was a Board Member at 2-BBB. Henk Brulleman studied Business Economics at the Free University in Amsterdam. He started his career at Royal Dutch Shell and rose to the position of deputy chief investment officer. He then became a partner at Numeric Investors LLC, a Boston-based quantitative equity management firm, where he co-managed portfolios with a combined value of $3 billion and handled client relations, marketing, and modeling. After retiring from Numeric, he built a portfolio of several equity and convertible debt stakes, predominantly in the field of life sciences, pharmaceuticals, and medical technology. After five years of retirement, he recently joined Wolkers & Co, a multi-family fiduciary asset management office, as a partner.